Financhill
Sell
50

NTRB Quote, Financials, Valuation and Earnings

Last price:
$8.07
Seasonality move :
-25.87%
Day range:
$7.81 - $8.28
52-week range:
$3.72 - $11.78
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
36.83x
P/B ratio:
17.36x
Volume:
43.6K
Avg. volume:
132.2K
1-year change:
33.78%
Market cap:
$88.6M
Revenue:
$2.1M
EPS (TTM):
-$0.90

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
NTRB
Nutriband
$665K -$0.17 59.2% -13.33% $15.00
IVF
INVO Fertility
$1.7M -- -8.8% -- --
NMTC
NeuroOne Medical Technologies
$1.8M -- 120.4% -57.14% $1.45
NVNO
enVVeno Medical
-- -$0.28 -- -9.68% $12.50
SINT
SINTX Technologies
$400K -$0.79 5.82% -78.12% $28.00
XAIR
Beyond Air
$1.7M -- 155.97% -- $2.25
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
NTRB
Nutriband
$7.96 $15.00 $88.6M -- $0.00 0% 36.83x
IVF
INVO Fertility
$0.78 -- $1.7M -- $0.00 0% 0.07x
NMTC
NeuroOne Medical Technologies
$0.71 $1.45 $35.5M -- $0.00 0% 3.68x
NVNO
enVVeno Medical
$4.18 $12.50 $73.3M -- $0.00 0% 407.78x
SINT
SINTX Technologies
$3.33 $28.00 $8.4M -- $0.00 0% 3.19x
XAIR
Beyond Air
$0.17 $2.25 $800.8K -- $0.00 0% 63.05x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
NTRB
Nutriband
3.43% 1.334 0.24% 3.31x
IVF
INVO Fertility
65.97% 1.151 20.29% 0.05x
NMTC
NeuroOne Medical Technologies
-- 0.459 -- 0.93x
NVNO
enVVeno Medical
-- 1.389 -- --
SINT
SINTX Technologies
2.11% 1.788 1.98% 2.98x
XAIR
Beyond Air
41.93% 0.040 42.16% 1.56x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
NTRB
Nutriband
$252K -$1.4M -100.04% -102.63% -207.21% -$1.3M
IVF
INVO Fertility
$592.3K -$2.5M -313.33% -714.24% -1044.01% -$3.6M
NMTC
NeuroOne Medical Technologies
$771.1K -$2.7M -281.01% -281.01% -163.76% -$59.3K
NVNO
enVVeno Medical
-- -$5M -- -- -- -$4M
SINT
SINTX Technologies
$45K -$2.4M -177.02% -180.99% -783.16% -$1.4M
XAIR
Beyond Air
-$32K -$7.2M -146.65% -218.07% -649.57% -$8.5M

Nutriband vs. Competitors

  • Which has Higher Returns NTRB or IVF?

    INVO Fertility has a net margin of -208.09% compared to Nutriband's net margin of -1063.02%. Nutriband's return on equity of -102.63% beat INVO Fertility's return on equity of -714.24%.

    Company Gross Margin Earnings Per Share Invested Capital
    NTRB
    Nutriband
    37.75% -$0.12 $5.3M
    IVF
    INVO Fertility
    36.18% -$12.53 $9.8M
  • What do Analysts Say About NTRB or IVF?

    Nutriband has a consensus price target of $15.00, signalling upside risk potential of 88.44%. On the other hand INVO Fertility has an analysts' consensus of -- which suggests that it could grow by 673.4%. Given that INVO Fertility has higher upside potential than Nutriband, analysts believe INVO Fertility is more attractive than Nutriband.

    Company Buy Ratings Hold Ratings Sell Ratings
    NTRB
    Nutriband
    1 0 0
    IVF
    INVO Fertility
    0 0 0
  • Is NTRB or IVF More Risky?

    Nutriband has a beta of 1.226, which suggesting that the stock is 22.565% more volatile than S&P 500. In comparison INVO Fertility has a beta of 2.045, suggesting its more volatile than the S&P 500 by 104.471%.

  • Which is a Better Dividend Stock NTRB or IVF?

    Nutriband has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband pays -- of its earnings as a dividend. INVO Fertility pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NTRB or IVF?

    Nutriband quarterly revenues are $667.4K, which are smaller than INVO Fertility quarterly revenues of $1.6M. Nutriband's net income of -$1.4M is higher than INVO Fertility's net income of -$17.4M. Notably, Nutriband's price-to-earnings ratio is -- while INVO Fertility's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband is 36.83x versus 0.07x for INVO Fertility. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NTRB
    Nutriband
    36.83x -- $667.4K -$1.4M
    IVF
    INVO Fertility
    0.07x -- $1.6M -$17.4M
  • Which has Higher Returns NTRB or NMTC?

    NeuroOne Medical Technologies has a net margin of -208.09% compared to Nutriband's net margin of -163.76%. Nutriband's return on equity of -102.63% beat NeuroOne Medical Technologies's return on equity of -281.01%.

    Company Gross Margin Earnings Per Share Invested Capital
    NTRB
    Nutriband
    37.75% -$0.12 $5.3M
    NMTC
    NeuroOne Medical Technologies
    55.61% -$0.07 $1.1M
  • What do Analysts Say About NTRB or NMTC?

    Nutriband has a consensus price target of $15.00, signalling upside risk potential of 88.44%. On the other hand NeuroOne Medical Technologies has an analysts' consensus of $1.45 which suggests that it could grow by 103.65%. Given that NeuroOne Medical Technologies has higher upside potential than Nutriband, analysts believe NeuroOne Medical Technologies is more attractive than Nutriband.

    Company Buy Ratings Hold Ratings Sell Ratings
    NTRB
    Nutriband
    1 0 0
    NMTC
    NeuroOne Medical Technologies
    1 0 0
  • Is NTRB or NMTC More Risky?

    Nutriband has a beta of 1.226, which suggesting that the stock is 22.565% more volatile than S&P 500. In comparison NeuroOne Medical Technologies has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.052%.

  • Which is a Better Dividend Stock NTRB or NMTC?

    Nutriband has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband pays -- of its earnings as a dividend. NeuroOne Medical Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NTRB or NMTC?

    Nutriband quarterly revenues are $667.4K, which are smaller than NeuroOne Medical Technologies quarterly revenues of $1.4M. Nutriband's net income of -$1.4M is higher than NeuroOne Medical Technologies's net income of -$2.3M. Notably, Nutriband's price-to-earnings ratio is -- while NeuroOne Medical Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband is 36.83x versus 3.68x for NeuroOne Medical Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NTRB
    Nutriband
    36.83x -- $667.4K -$1.4M
    NMTC
    NeuroOne Medical Technologies
    3.68x -- $1.4M -$2.3M
  • Which has Higher Returns NTRB or NVNO?

    enVVeno Medical has a net margin of -208.09% compared to Nutriband's net margin of --. Nutriband's return on equity of -102.63% beat enVVeno Medical's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    NTRB
    Nutriband
    37.75% -$0.12 $5.3M
    NVNO
    enVVeno Medical
    -- -$0.22 --
  • What do Analysts Say About NTRB or NVNO?

    Nutriband has a consensus price target of $15.00, signalling upside risk potential of 88.44%. On the other hand enVVeno Medical has an analysts' consensus of $12.50 which suggests that it could grow by 199.04%. Given that enVVeno Medical has higher upside potential than Nutriband, analysts believe enVVeno Medical is more attractive than Nutriband.

    Company Buy Ratings Hold Ratings Sell Ratings
    NTRB
    Nutriband
    1 0 0
    NVNO
    enVVeno Medical
    1 0 0
  • Is NTRB or NVNO More Risky?

    Nutriband has a beta of 1.226, which suggesting that the stock is 22.565% more volatile than S&P 500. In comparison enVVeno Medical has a beta of 0.932, suggesting its less volatile than the S&P 500 by 6.781%.

  • Which is a Better Dividend Stock NTRB or NVNO?

    Nutriband has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband pays -- of its earnings as a dividend. enVVeno Medical pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NTRB or NVNO?

    Nutriband quarterly revenues are $667.4K, which are larger than enVVeno Medical quarterly revenues of --. Nutriband's net income of -$1.4M is higher than enVVeno Medical's net income of -$4.5M. Notably, Nutriband's price-to-earnings ratio is -- while enVVeno Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband is 36.83x versus 407.78x for enVVeno Medical. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NTRB
    Nutriband
    36.83x -- $667.4K -$1.4M
    NVNO
    enVVeno Medical
    407.78x -- -- -$4.5M
  • Which has Higher Returns NTRB or SINT?

    SINTX Technologies has a net margin of -208.09% compared to Nutriband's net margin of -787.63%. Nutriband's return on equity of -102.63% beat SINTX Technologies's return on equity of -180.99%.

    Company Gross Margin Earnings Per Share Invested Capital
    NTRB
    Nutriband
    37.75% -$0.12 $5.3M
    SINT
    SINTX Technologies
    15.46% -$1.29 $6.2M
  • What do Analysts Say About NTRB or SINT?

    Nutriband has a consensus price target of $15.00, signalling upside risk potential of 88.44%. On the other hand SINTX Technologies has an analysts' consensus of $28.00 which suggests that it could grow by 740.84%. Given that SINTX Technologies has higher upside potential than Nutriband, analysts believe SINTX Technologies is more attractive than Nutriband.

    Company Buy Ratings Hold Ratings Sell Ratings
    NTRB
    Nutriband
    1 0 0
    SINT
    SINTX Technologies
    1 0 0
  • Is NTRB or SINT More Risky?

    Nutriband has a beta of 1.226, which suggesting that the stock is 22.565% more volatile than S&P 500. In comparison SINTX Technologies has a beta of 0.713, suggesting its less volatile than the S&P 500 by 28.749%.

  • Which is a Better Dividend Stock NTRB or SINT?

    Nutriband has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband pays -- of its earnings as a dividend. SINTX Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NTRB or SINT?

    Nutriband quarterly revenues are $667.4K, which are larger than SINTX Technologies quarterly revenues of $291K. Nutriband's net income of -$1.4M is higher than SINTX Technologies's net income of -$2.3M. Notably, Nutriband's price-to-earnings ratio is -- while SINTX Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband is 36.83x versus 3.19x for SINTX Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NTRB
    Nutriband
    36.83x -- $667.4K -$1.4M
    SINT
    SINTX Technologies
    3.19x -- $291K -$2.3M
  • Which has Higher Returns NTRB or XAIR?

    Beyond Air has a net margin of -208.09% compared to Nutriband's net margin of -697.4%. Nutriband's return on equity of -102.63% beat Beyond Air's return on equity of -218.07%.

    Company Gross Margin Earnings Per Share Invested Capital
    NTRB
    Nutriband
    37.75% -$0.12 $5.3M
    XAIR
    Beyond Air
    -2.78% -$0.09 $24.1M
  • What do Analysts Say About NTRB or XAIR?

    Nutriband has a consensus price target of $15.00, signalling upside risk potential of 88.44%. On the other hand Beyond Air has an analysts' consensus of $2.25 which suggests that it could grow by 25971.84%. Given that Beyond Air has higher upside potential than Nutriband, analysts believe Beyond Air is more attractive than Nutriband.

    Company Buy Ratings Hold Ratings Sell Ratings
    NTRB
    Nutriband
    1 0 0
    XAIR
    Beyond Air
    2 1 0
  • Is NTRB or XAIR More Risky?

    Nutriband has a beta of 1.226, which suggesting that the stock is 22.565% more volatile than S&P 500. In comparison Beyond Air has a beta of 0.221, suggesting its less volatile than the S&P 500 by 77.879%.

  • Which is a Better Dividend Stock NTRB or XAIR?

    Nutriband has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Beyond Air offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nutriband pays -- of its earnings as a dividend. Beyond Air pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NTRB or XAIR?

    Nutriband quarterly revenues are $667.4K, which are smaller than Beyond Air quarterly revenues of $1.2M. Nutriband's net income of -$1.4M is higher than Beyond Air's net income of -$8M. Notably, Nutriband's price-to-earnings ratio is -- while Beyond Air's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nutriband is 36.83x versus 63.05x for Beyond Air. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NTRB
    Nutriband
    36.83x -- $667.4K -$1.4M
    XAIR
    Beyond Air
    63.05x -- $1.2M -$8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Oklo Stock Double?
Will Oklo Stock Double?

Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…

Why a $5 Stock Is Suddenly a Cash Machine
Why a $5 Stock Is Suddenly a Cash Machine

If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…

Is Roku Stock Undervalued Now?
Is Roku Stock Undervalued Now?

At roughly $89 a share, Roku (NASDAQ: ROKU) trades for barely…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
45
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
58
INKT alert for Jul 14

MiNK Therapeutics [INKT] is down 36.03% over the past day.

Buy
51
NEGG alert for Jul 14

Newegg Commerce [NEGG] is down 26.42% over the past day.

Buy
68
ATRO alert for Jul 14

Astronics [ATRO] is down 1.02% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock